Linden Capital Partners – a Chicago-based healthcare private equity firm – announced the closing of Linden Structured Capital Fund II (SCF II. This fund closed with $400 million of commitments, exceeding the prior structured capital fund (SCF I) size of approximately $355 million.
SCF II – like Linden’s first Structured Capital Fund—is focused on investing in middle-market healthcare companies via securities with debt—and equity-like features. The fund has made 8 investments to date, including its first full realization at the end of last year.
The participants in SCF II include a range of SCF I investors, including pension plans, insurance companies, family offices, asset managers, and new investors from the United States, Europe, Asia, and the Middle East.
Kirkland & Ellis served as fund counsel, and PJT Park Hill served as placement advisor.
KEY QUOTES:
“Our mission to create and support exceptional companies, coupled with our deep and experienced team and network, continues to strengthen our position as the largest healthcare-dedicated manager. The support of our existing and new investors in SCF II underscores our approach, and we’re proud to announce this milestone.”
– Linden’s Co-Founder and President, Tony Davis
“Our portfolio continues to highlight Linden Structured Capital’s ability to be a value-added partner to healthcare companies and their equity sponsors, management teams, and founders, leveraging Linden’s healthcare franchise, network, and infrastructure to support our investment strategy. The performance of SCF I and demand we’ve seen in SCF II amidst the current market affirms our strategy, underscores our firm’s durability, and we believe positions us well to continue to drive results for our investors.”
– Linden Structured Capital Partner Scott Gallin
